On 29 June 2015 the President of Ukraine signed Decrees No. 372 / 2015-384 / 2015, which changed the current composition of the Antimonopoly Committee of Ukraine by appointment of the new public officials of the Antimonopoly Committee of Ukraine (hereinafter - "public officials").
The procedure for appointment and dismissal of state officials is determined by the Art. 12 of the Law of Ukraine No. 3659-XII dated 26 November 1993, which stipulates that public officials shall be appointed on the recommendation of the Prime Minister of Ukraine and dismissed by the President of Ukraine.
Proposals for the appointment of public officials are submitted to the Prime Minister of Ukraine by initiative of the Chair of the Antimonopoly Committee of Ukraine. As it is known, on 19 May 2015 Yuri Terentiev was appointed as the Chair of the Antimonopoly Committee of Ukraine by the High Council of Ukraine.
Having signed the Decrees mentioned above, President Poroshenko dismissed five public officials, namely, Mikhail Rusinsky, Valeria Dadiverina, Svetlana Moroz, Sergey Shershun and Nikolay Barash.
By virtue of the aforesaid Decrees, the President appointed 8 persons as public officials,namely Andrey Vovk, Agiya Zagrebelska, Maria Nizhnik, Maria Protsishen, Svetlana Panaiotidi, Nina Sidorenko, Valeriy Polukhovich and Anna Artemenko.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
